Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03734588
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:56.906697+00:00
Published At
2024-02-23T00:00:00+00:00
Record Updated At
2024-02-23
Results Posted At
2024-02-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adeno-Associated Virus (AAV)", "Blood Coagulation Disorder", "Blood Coagulation Disorders, Inherited", "Coagulation Protein Disorders", "Factor VIII (FVIII)", "Factor VIII (FVIII) Deficiency", "Factor VIII (FVIII) Gene", "Factor VIII (FVIII) Protein", "Genetic Diseases, Inborn", "Genetic Diseases, X-Linked", "Gene Therapy", "Gene Transfer", "Hematologic Diseases", "Hemorrhagic Disorders", "Recombinant", "Vector", "Inhibitors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-23"
protocolSection.identificationModule.nctId
"NCT03734588"
protocolSection.identificationModule.officialTitle
"Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-02-23"

Study condition terms

  • Adeno-Associated Virus (AAV) (protocolSection.conditionsModule.conditions)
  • Blood Coagulation Disorder (protocolSection.conditionsModule.conditions)
  • Blood Coagulation Disorders, Inherited (protocolSection.conditionsModule.conditions)
  • Coagulation Protein Disorders (protocolSection.conditionsModule.conditions)
  • Factor VIII (FVIII) (protocolSection.conditionsModule.conditions)
  • Factor VIII (FVIII) Deficiency (protocolSection.conditionsModule.conditions)
  • Factor VIII (FVIII) Gene (protocolSection.conditionsModule.conditions)
  • Factor VIII (FVIII) Protein (protocolSection.conditionsModule.conditions)
  • Genetic Diseases, Inborn (protocolSection.conditionsModule.conditions)
  • Genetic Diseases, X-Linked (protocolSection.conditionsModule.conditions)
  • Gene Therapy (protocolSection.conditionsModule.conditions)
  • Gene Transfer (protocolSection.conditionsModule.conditions)
  • Hematologic Diseases (protocolSection.conditionsModule.conditions)
  • Hemorrhagic Disorders (protocolSection.conditionsModule.conditions)
  • Recombinant (protocolSection.conditionsModule.conditions)
  • Vector (protocolSection.conditionsModule.conditions)
  • Inhibitors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.